Australia · Delayed Price · Currency is AUD Orica Earnings Call Transcripts
Fiscal Year 2026
-
Record first half EBIT and NPAT pre-significant items, strong growth in premium products, digital and specialty chemicals, and robust shareholder returns. Strategic acquisitions and cost reduction initiatives support a positive outlook, despite ongoing market volatility.
Fiscal Year 2025
-
Record earnings and strong cash flow were achieved, with a 23% EBIT increase and major progress on sustainability targets. Board renewal saw Vik Bansal elected as chair, and all resolutions passed. Strategic focus remains on safety, innovation, and decarbonization.
-
Record financial and safety performance with double-digit profit growth, strong cash flow, and robust segment results. Outlook remains positive with continued EBIT growth expected across all segments, supported by technology adoption and favorable commodity markets.
-
Record half-year EBIT and strong cash flow were driven by premium product demand, technology adoption, and successful acquisitions. All segments and regions delivered growth, with robust outlook and continued capital discipline supporting increased shareholder returns.
-
Revised summary: The company is integrating core blasting, specialty mining chemicals, and digital solutions, with progress in decarbonization, digital transformation, and acquisitions. A new capital framework features a leverage target and AUD 400 million buyback, while growth is driven by technology, efficiency, and new markets.
Fiscal Year 2024
-
The meeting highlighted a decade-best financial performance, strong dividend payout, and major progress in sustainability and strategic acquisitions. Shareholders discussed governance, report access, and registry issues, while all resolutions passed with strong support.
-
EBIT rose 15% to AUD 806 million, with all segments and regions reporting earnings growth. Specialty mining chemicals and digital solutions saw strong expansion, and sustainability targets were achieved ahead of schedule. FY 2025 guidance anticipates continued EBIT growth and robust capital management.